Diancecht Pharmaceuticals Private Limited

Diancecht Pharmaceuticals Private Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
CIN U24100CH2008PTC031383 Incorporated 24 September 2008 ROC Chandigarh HQ Chandigarh, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2026
₹2.48 Cr
▼ 5% YoY
Net profit · FY 2026
₹70,450
Net margin 0.3%
EBITDA · FY 2026
₹94,441
EBITDA margin 0.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
18 yrs
Est. 2008
Directors on board
5
As per MCA filings
Active GSTINs
1
GST registered

About Diancecht Pharmaceuticals Private Limited

Data last updated:

Diancecht Pharmaceuticals Private Limited is a private limited company based in Chandigarh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 September 2008 and has been in existence for over 18 years.

The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24100CH2008PTC031383. Its GSTIN is 04AADCD0164A1ZJ (Chandigarh).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Dianacecht Pharmaceuticals Private Limited. It is led by directors including Arun Sharma and Umesh Kumar.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Scf No. 478 First Floor Backside Portion Motor Market Manimajra, Chandigarh, India – 160101.

As per the financials filed for FY 2026, the company reported a revenue of ₹2.48 Cr, a decline of 5% compared to the previous year. For the same year it recorded a net profit of ₹70,450 (net margin 0.3%) and EBITDA of ₹94,441 (EBITDA margin 0.4%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 11% over five years.

Court records list 1 case involving the company, including 1 filed against it; 1 case is pending.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24100CH2008PTC031383
Registration Number 031383
Incorporation Date 24 September 2008
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant

Contact details

Diancecht Pharmaceuticals Private Limited's registered office is in Chandigarh, Chandigarh. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Scf No. 478 First Floor Backside Portion Motor Market Manimajra, Chandigarh, India – 160101
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Diancecht Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Diancecht Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Diancecht Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale and retail trade and repair of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles45Wholesale and retail trade and repair of motor vehicles and motorcycles

To see the full business activity and turnover split of Diancecht Pharmaceuticals Private Limited, buy the company report.

Financials of Diancecht Pharmaceuticals Private Limited

FY 2026 filings available

Diancecht Pharmaceuticals Private Limited reported revenue of ₹2.48 Cr (down 5% YoY) for FY 2026.

Revenue · FY 2026
₹2.48 Cr ▼ 5%
Net profit · FY 2026
₹70,450 margin 0.3%
EBITDA · FY 2026
₹94,441 margin 0.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 5%
3 years · compounded
▼ 2%
5 years · compounded
▲ 11%
EBITDA CAGR growth
3 years · compounded
▼ 58%
5 years · compounded
▼ 40%

Revenue fell 5% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 11%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹2.48 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹94,441
Profit Before Tax
Tax Expense
Net Profit (PAT)₹70,450
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
EBITDA Margin0.4%
Net Profit Margin0.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Diancecht Pharmaceuticals Private Limited, buy the company report.

Board of directors of Diancecht Pharmaceuticals Private Limited

Diancecht Pharmaceuticals has 5 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Arun SharmaDirector05 Jan 201115 Years 10 MonthsCurrent
Umesh KumarDirector05 Jan 201115 Years 10 MonthsCurrent
Harjit Singh ChawlaDirector01 Nov 201016 Years 0 MonthsCurrent
Jagjit MahajanDirector01 Nov 201016 Years 0 MonthsCurrent
Jagdeep SinghDirector05 Jan 201115 Years 10 MonthsCurrent

Auditor

Diancecht Pharmaceuticals Private Limited is audited by Ajay Wadhawan & Company for the financial year 2026.

Auditor firmFinancial yearFirm registration number
Ajay Wadhawan & CompanyFY 2026508999

Shareholding

The shareholding of Diancecht Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2026FY 2025FY 2023FY 2022FY 2021
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Diancecht Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Diancecht Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Diancecht Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
04AADCD0164A1ZJChandigarhActive01 Jul 2017

To see the full GST registrations and return filing status of Diancecht Pharmaceuticals Private Limited, buy the company report.

Recent activity

Diancecht Pharmaceuticals Private Limited has 15 board changes on record since 2009: 5 appointments and 10 cessations. The latest: Arun Sharma was appointed as Director on 05 Jan 2011.

Filing
Diancecht Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Chandigarh.
AGM
Diancecht Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Appointed
Arun Sharma was appointed as Director.
Ceased
Ishwar Dass ceased to be Director.
Appointed
Jagdeep Singh was appointed as Director.
Ceased
Labh Singh ceased to be Director.
Ceased
Rama Sharma ceased to be Director.
Appointed
Umesh Kumar was appointed as Director.
Ceased
Arjun Mahajan ceased to be Director.
Ceased
Gurcharan Singh Chawla ceased to be Director.
Appointed
Harjit Singh Chawla was appointed as Director.
Appointed
Jagjit Mahajan was appointed as Director.

6 earlier events are in the company report.

Frequently asked questions

Diancecht Pharmaceuticals is an active private limited company based in Chandigarh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 September 2008 (18+ years old) and is registered under CIN U24100CH2008PTC031383.

Diancecht Pharmaceuticals has 5 current directors:

The latest financial statements of Diancecht Pharmaceuticals on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.

The GSTIN of Diancecht Pharmaceuticals is 04AADCD0164A1ZJ, registered in Chandigarh.

The CIN (Corporate Identification Number) of Diancecht Pharmaceuticals is U24100CH2008PTC031383. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Diancecht Pharmaceuticals has 1 court case on record: 1 filed against it. 1 is pending.

Diancecht Pharmaceuticals was incorporated on 24 September 2008, making it 18+ years old. It is registered with the Registrar of Companies, Chandigarh.

Arun Sharma was appointed as Director on 05 Jan 2011. Ishwar Dass ceased to be Director on 05 Jan 2011. Jagdeep Singh was appointed as Director on 05 Jan 2011. Diancecht Pharmaceuticals has 15 board changes on record in total.

The registered office of Diancecht Pharmaceuticals is at Scf No. 478 First Floor Backside Portion Motor Market Manimajra, Chandigarh, India – 160101.

Diancecht Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.